Ladenburg Thalmann Starts Nektar Therapeutics (NKTR) at Buy
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Price: $70.68 -2.54%
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Join SI Premium – FREE
Ladenburg Thalmann initiated coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating and a price target of $20.00.
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $12.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Starts Gorilla Tech Group (GRRR) at Buy
- Needham Starts AirJoule Technologies (AIRJ) at Hold
- Rodman & Renshaw Starts (QNTM) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
